OSE Immunotherapeutics Statistics

Total Valuation

LON:0RAD has a market cap or net worth of GBP 85.35 million. The enterprise value is 92.19 million.

Market Cap	85.35M
Enterprise Value	92.19M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	22.42M
Shares Outstanding	n/a
Shares Change (YoY)	+3.76%
Shares Change (QoQ)	+3.65%
Owned by Insiders (%)	24.14%
Owned by Institutions (%)	3.17%
Float	16.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	54.90
PB Ratio	2.92
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.25
EV / Sales	59.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.91

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 1.06.

Current Ratio	1.54
Quick Ratio	1.19
Debt / Equity	1.06
Debt / EBITDA	n/a
Debt / FCF	-1.32
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.82% and return on invested capital (ROIC) is -66.55%.

Return on Equity (ROE)	-66.82%
Return on Assets (ROA)	-18.42%
Return on Invested Capital (ROIC)	-66.55%
Return on Capital Employed (ROCE)	-50.40%
Weighted Average Cost of Capital (WACC)	5.17%
Revenue Per Employee	24,290
Profits Per Employee	-443,261
Employee Count	64
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.91% in the last 52 weeks. The beta is 0.51, so LON:0RAD's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-31.91%
50-Day Moving Average	5.03
200-Day Moving Average	5.70
Relative Strength Index (RSI)	34.19
Average Volume (20 Days)	194

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RAD had revenue of GBP 1.55 million and -28.37 million in losses. Loss per share was -1.29.

Revenue	1.55M
Gross Profit	1.55M
Operating Income	-26.76M
Pretax Income	-28.37M
Net Income	-28.37M
EBITDA	-25.71M
EBIT	-26.76M
Loss Per Share	-1.29

Full Income Statement

Balance Sheet

The company has 24.26 million in cash and 31.11 million in debt, with a net cash position of -6.85 million.

Cash & Cash Equivalents	24.26M
Total Debt	31.11M
Net Cash	-6.85M
Net Cash Per Share	n/a
Equity (Book Value)	29.24M
Book Value Per Share	1.33
Working Capital	10.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.21 million and capital expenditures -392,568, giving a free cash flow of -23.60 million.

Operating Cash Flow	-23.21M
Capital Expenditures	-392,568
Free Cash Flow	-23.60M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,721.44%
Pretax Margin	-1,824.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0RAD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.76%
Shareholder Yield	-3.76%
Earnings Yield	-33.24%
FCF Yield	-27.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2